Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-19-001345
Filing Date
2019-05-02
Accepted
2019-05-02 17:33:30
Documents
1
Period of Report
2019-04-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3789
  Complete submission text file 0001683168-19-001345.txt   5270
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARINA BIOTECH, INC. 17870 CASTLETON STREET, SUITE 250 CITY OF INDUSTRY CA 91748
Business Address
Hwang Larn (Reporting) CIK: 0001697480 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 19793293